Journal article · 2018 · Open access
Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers
Frontiers in Medicine, 5, 69 · Published 15 March 2018 · DOI 10.3389/fmed.2018.00069
In brief
“Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers” is a 2018 journal article by Mehdi Shafa and 4 co-authors, published in Frontiers in Medicine. OpenAlex counts 38 citations as of 21 November 2026, which puts it in the top 8% of works published in 2018 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Medicine.
- Citations
- 38
- Most cited in
- 2021 (10)
- Field-weighted impact
- 1.39
- References
- 52
- Authors
- 5
Abstract
The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has revolutionized the field of regenerative medicine and opened new opportunities in cell replacement therapies. While generation of iPSCs represents a significant breakthrough, the clinical relevance of iPSCs for cell-based therapies requires generation of high-quality specialized cells through robust and reproducible directed differentiation protocols. We have recently reported manufacturing of human iPSC master cell banks (MCB) under current good manufacturing practices (cGMPs). Here, we describe the clinical potential of human iPSCs generated using this cGMP-compliant process by differentiating them into the cells from all three embryonic germ layers including ectoderm, endoderm, and mesoderm. Most importantly, we have shown that our iPSC manufacturing process and cell culture system is not biased toward a specific lineage. Following controlled induction into a specific differentiation lineage, specialized cells with morphological and cellular characteristics of neural stem cells, definitive endoderm, and cardiomyocytes were developed. We believe that these cGMP-compliant iPSCs have the potential to make various clinically relevant products suitable for cell therapy applications.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Shafa, M., Yang, F., Fellner, T., Rao, M. S., & Baghbaderani, B. A. (2018). Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers. Frontiers in Medicine, 5, 69. https://doi.org/10.3389/fmed.2018.00069
MLA 9
Shafa, Mehdi, et al. “Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers.” Frontiers in Medicine, vol. 5, 2018, p. 69. https://doi.org/10.3389/fmed.2018.00069.
Chicago
Shafa, Mehdi, Fan Yang, Thomas Fellner, Mahendra S. Rao, and Behnam Ahmadian Baghbaderani. 2018. “Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers.” Frontiers in Medicine 5: 69. https://doi.org/10.3389/fmed.2018.00069.
Harvard
Shafa, M. et al. (2018) ‘Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers’, Frontiers in Medicine, 5, p. 69. doi:10.3389/fmed.2018.00069.
IEEE
M. Shafa, F. Yang, T. Fellner, M. S. Rao, and B. A. Baghbaderani, “Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers,” Frontiers in Medicine, vol. 5, p. 69, 2018, doi: 10.3389/fmed.2018.00069.
BibTeX
@article{shafa2018human,
title = {{Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers}},
author = {Shafa, Mehdi and Yang, Fan and Fellner, Thomas and Rao, Mahendra S. and Baghbaderani, Behnam Ahmadian},
journal = {Frontiers in Medicine},
year = {2018},
volume = {5},
pages = {69},
doi = {10.3389/fmed.2018.00069},
url = {https://doi.org/10.3389/fmed.2018.00069}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 2 | |
| 2019 | 5 | |
| 2020 | 3 | |
| 2021 | 10 | |
| 2022 | 4 | |
| 2023 | 3 | |
| 2024 | 6 | |
| 2025 | 3 | |
| 2026 | 2 |
Its field-weighted citation impact is 1.39: it has been cited 1.39 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- human induced pluripotent stem cells
- current good manufacturing practice
- directed differentiation
- germ layer differentiation
- neural stem cells
- definitive endoderm
- cardiomyocytes
- cell therapy
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Shafa, M., Yang, F., Fellner, T., Rao, M. S., & Baghbaderani, B. A. (2018). Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers. Frontiers in Medicine, 5, 69. https://doi.org/10.3389/fmed.2018.00069
How many times has this paper been cited?
38 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Medicine: sign in and open the PDF from this page.
Who wrote this paper?
Mehdi Shafa, Fan Yang, Thomas Fellner, Mahendra S. Rao, Behnam Ahmadian Baghbaderani.
What is the DOI of this paper?
10.3389/fmed.2018.00069, permanently at https://doi.org/10.3389/fmed.2018.00069. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.